Skip to main content
. 2024 Sep 20;17:6563–6581. doi: 10.2147/JIR.S489682

Table 1.

Role of LncRNA in OA Inflammation

LncRNA Expression in OA Role in OA Inflammation Pathways/Targets/Mechanisms Reference
MALAT1 Upregulated Enhances the expression and release of inflammatory mediators; modulates cellular responses like pyroptosis and apoptosis Modulates NF-κB, TLR4, Wnt/β-catenin, PI3K/Akt/mTOR; acts as a ceRNA interacting with miR-146a, miR-145, miR-9; affects cytokine release, ECM degradation, and cell proliferation. [91–96]
PVT1 Upregulated Promotes inflammatory responses, ECM degradation, and chondrocyte apoptosis. Influences TLR4/NF-κB TGF-β/SMAD4 pathways; acts as a ceRNA; targets such as miR −146a, miR-93-5p, miR-27b-3p, miR-140, miR-211-3p influencing MMP and cytokine levels. [100–102,104,105,107]
H19 Upregulated Enhance the release of inflammatory cytokines, affect the vitality and proliferation of chondrocytes, and promote angiogenesis Regulates pathways like NF-κB, TLR4, JNK and AKT; interacts with miR-106a-5p, miR130a, miR-103a affecting cytokine levels and ECM components. [113–116,118]
HOTAIR Upregulated Contributes to chondrocyte apoptosis and inflammatory responses. Regulates pathways like NF-κB/TNFα, MAPK/c-Jun; modulates miRNA function impacting inflammatory signaling and ECM degradation such as miR-1277-5P, miR-107, miR-222-3p, miR-17-3p [123,125–128]
NEAT1 Upregulated Targets miRNAs to regulate inflammation and apoptosis in chondrocytes. Involves Wnt/β-catenin and NF-κB pathways; interacts with miRNAs like miR-543, miR-146a-3p, miR-193a-3p, miR-16-5p affecting inflammation-related gene expression. [120,130,131,133–136]
THRIL Upregulated Promotes inflammation and chondrocyte apoptosis, exacerbates inflammatory injury. Modulates JAK1/STAT3, NF-κB, PI3K/AKT pathways; influences cytokine production and cellular viability. [139,140]
XIST Upregulated Regulates gene expression related to inflammation and chondrocyte viability. Acts as a ceRNA for miR-149-5p, miR-376c-5p; interacts with pathways like PI3K/Akt and affects cytokine levels and ECM components. [142–144]
MEG3 Downregulated Plays a role in reducing inflammatory responses, chondrocyte apoptosis and reduces angiogenesis. Regulation of miR-16, miR-93 and other miRNAs; It affects TGF-β, TLR4/ NF-κB pathway and ECM degradation [146,150,151,153,155,156]
GAS5 Downregulated Inhibits chondrocyte apoptosis and modulates inflammatory responses. Functions as a ceRNA for miR-146a; impacts Smad4 expression and inflammatory signaling pathways. [158–160]
NKILA Downregulated Inhibit the activation of NF-κB, reduce the expression of inflammatory mediators and angiogenesis Stabilizes the NF-κB/IκB complex; modulates inflammation and cellular responses in chondrocytes. [162–164]
ATB Downregulated Reduces inflammatory mediators and promotes chondrocyte viability. Regulates Akt phosphorylation; affects MyD88 and p38 in the TLR4/NF-κB and MAPK pathways. [166,167]
PACER Downregulated Modulates affecting inflammatory responses and cartilage degeneration. Interacts with NF-κB p50 subunit [169]
OIP5-AS1 Downregulated Mitigates inflammatory responses and promotes chondrocyte viability. Regulates PI3K/AKT pathway, AMPK/Akt/mTOR; interacts with miR-338-3p affecting cytokine expression and ECM integrity. [173–175]